LMGF(SZ:002734)2018-08-29 16:00Financial Performance - The company's operating revenue for the first half of 2018 was CNY 712,431,287.53, representing a 7.76% increase compared to CNY 661,101,274.69 in the same period last year[16]. - The net profit attributable to shareholders of the listed company reached CNY 102,957,447.31, marking a 30.37% increase from CNY 78,971,870.29 year-on-year[16]. - The net profit after deducting non-recurring gains and losses was CNY 99,587,255.23, up 24.15% from CNY 80,218,082.22 in the previous year[16]. - The basic earnings per share increased to CNY 0.37, a rise of 27.59% compared to CNY 0.29 in the same period last year[16]. - The total operating revenue for the reporting period was CNY 712,431,287.53, representing a year-on-year increase of 7.76% compared to CNY 661,101,274.69 in the same period last year[39]. - Revenue from the pesticide segment reached CNY 705,190,712.31, accounting for 98.98% of total revenue, with a year-on-year growth of 13.55%[39]. - The net profit attributable to the parent company reached 102.96 million yuan, an increase of 30.37% compared to the previous year[32]. - The company reported a significant increase in prepayments, which rose to ¥46,076,872.15 from ¥32,785,903.98, representing an increase of approximately 40.5%[135]. - The company reported a total investment of RMB 74,019.66 million in committed projects, with 100% completion for the acquisition of Hebei Shuangji and 36.03% for the efficient pesticide project[55]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,405,431,167.39, reflecting a 0.82% increase from CNY 2,385,880,926.07 at the end of the previous year[16]. - The net assets attributable to shareholders of the listed company were CNY 1,697,081,343.81, which is a 1.49% increase from CNY 1,672,136,629.52 at the end of the previous year[16]. - The total liabilities decreased to ¥650,050,237.66 from ¥656,054,966.35, showing a reduction of about 0.92%[137]. - The company's equity attributable to shareholders increased to ¥1,697,081,343.81 from ¥1,672,136,629.52, reflecting a growth of approximately 1.49%[138]. - The total equity at the end of the current period was 5,220,000,000 yuan[160]. - The total amount of special reserves at the end of the period was 1,860,200 yuan, with 6,084,600 yuan added during the period[160]. Cash Flow - The net cash flow from operating activities was negative at CNY -37,805,581.38, a significant decline of 247.34% compared to CNY 25,658,328.42 in the same period last year[16]. - The total cash and cash equivalents decreased by 60.91% to CNY -115,887,334.45, compared to CNY -296,474,045.00 in the previous year[41]. - The company reported a significant reduction in cash flow from financing activities, down 98.24% to CNY 1,808,006.03 from CNY 102,475,985.35 in the previous year[41]. - The ending balance of cash and cash equivalents was CNY 266,531,860.89, down from CNY 379,166,701.01 in the previous period[153]. - Total cash outflow from operating activities was CNY 610,439,073.96, compared to CNY 492,906,143.71 in the previous period, reflecting increased operational costs[152]. Market and Competition - The company is the largest domestic producer of protective fungicides, with a production capacity of nearly 40,000 tons for Dazhong fungicides[24]. - The company has established a strong international market presence, covering over 80 countries and regions, ranking among the top 30 in China's pesticide export volume[24]. - The company faces market competition risks, with potential impacts on product prices and profit margins, and plans to enhance product optimization and accelerate new product development to maintain competitive advantages[66]. - The company faces rising costs for the Dazhong series products due to raw material price increases, impacting sales in Southeast Asia[59]. Research and Development - The company has 15 authorized invention patents and 24 utility model patents, demonstrating its commitment to technological innovation[27]. - The company's R&D investment decreased by 4.77% to CNY 24,811,186.82 from CNY 26,054,664.72 in the previous year[41]. - The company is actively expanding its product registration, with 74 new registrations and 22 renewals in the international market during the first half of 2018[32]. Environmental Management - The company has established three comprehensive wastewater treatment facilities with a daily processing capacity of 7,800 tons[99]. - The company has implemented strict management standards for hazardous waste from generation to disposal[99]. - The company has been recognized as an advanced unit in environmental protection in the petroleum and chemical industry during the 12th Five-Year Plan[98]. - The company has signed an environmental pollution liability insurance contract and pays the insurance fees on time[98]. - The company has not faced any environmental administrative penalties or major pollution incidents during the reporting period[101]. Shareholder and Equity Information - The company’s total share capital increased to 279,585,220 shares after a capital increase of 114,876,267 shares through a bonus issue[112]. - The company has committed to not transferring or managing shares for 36 months from the date of stock listing[75]. - The company has no direct or indirect financial assistance to partners participating in the non-public offering[75]. - The total number of ordinary shareholders at the end of the reporting period was 14,677[118]. - The largest shareholder, Li Ming, holds 22.17% of the shares, totaling 61,990,500 shares[119]. Regulatory Compliance - The company adheres to the Chinese accounting standards, ensuring compliance and transparency in financial reporting[176]. - The company is subject to regulations regarding the management of restricted shares for executives and major shareholders[116]. - The report indicates a focus on maintaining compliance with securities regulations and shareholder rights[117]. - The company has not undergone any bankruptcy reorganization during the reporting period[79]. - There were no significant litigation or arbitration matters during the reporting period[80].